IV immunoglobulin does not reverse established weakness in MS.
Noseworthy JH, O'Brien PC, Weinshenker BG, Weis JA, Petterson TM, Erickson BJ, Windebank AJ, Whisnant JP, Stolp-Smith KA, Harper CM Jr, Low PA, Romme LJ, Johnson M, An KN, Rodriguez M.
Noseworthy JH, et al. Among authors: weinshenker bg.
Neurology. 2000 Oct 24;55(8):1135-43. doi: 10.1212/wnl.55.8.1135.
Neurology. 2000.
PMID: 11071491
Clinical Trial.